Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema)

Phase 3 Completed 73 enrolled Bayer Regeneron Pharmaceuticals · collab

NaSingle-groupOpen-labelTreatment

Summary

This study will assess the safety and tolerability of intravitreally (IVT) administered VEGF Trap-Eye in Japanese subjects with diabetic macular edema (DME) over the period of one year.

Timeline

Start: 2012-01
Primary completion: 2013-09
Completion: 2013-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Aflibercept	Protein / enzyme biologic	2 mg	Intravitreal

Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema)

Summary

Timeline

Drugs

Indications